Characterising meaningful patient and public involvement in the pharmaceutical industry research setting: a retrospective quality assessment

por Dews, Sally-Anne, Bassi, Adit, Buckland, Sean, Clements, Lucy, Daley, Rachel, Davies, Angela, Evett, Sophie, Howland, Samantha, Kinloch, Emma, Phillips, Berkeley, Powell, Gareth, Preston, Jennifer, Sterniczuk, Kamil, Bohm, Natalie
Publicado 2023

Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspective

por Blagden, Sarah P., Yu, Ly-Mee, Ellis, Stephanie, Hughes, Helen, Shaaban, Abeer, Fennelly-Barnwell, Jonathan, Lythgoe, Mark P., Cooper, Alison M., Maignen, Francois M., Buckland, Sean W., Kearns, Pamela R., Brown, Louise C.
Publicado 2022

Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement

por Blagden, Sarah P., Billingham, Lucinda, Brown, Louise C., Buckland, Sean W., Cooper, Alison M., Ellis, Stephanie, Fisher, Wendy, Hughes, Helen, Keatley, Debbie A., Maignen, Francois M., Morozov, Alex, Navaie, Will, Pearson, Sarah, Shaaban, Abeer, Wydenbach, Kirsty, Kearns, Pamela R.
Publicado 2020